Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Simian adenoviral vectors (SAd) offer an attractive alternative to standard human adenovirus serotype 5 (AdH5) subunit vaccination, due to pre-existing immunity affecting vaccine performance. We have used a mouse model of liver-stage malaria to test the efficiency of three chimpanzee-origin adenovir...
Hlavní autoři: | Reyes-Sandoval, A, Sridhar, S, Berthoud, T, Moore, A, Harty, J, Gilbert, S, Gao, G, Ertl, H, Wilson, J, Hill, A |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2008
|
Podobné jednotky
-
Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
Autor: Reyes-Sandoval, A, a další
Vydáno: (2011) -
Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
Autor: Reyes-Sandoval, A, a další
Vydáno: (2005) -
Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.
Autor: Sridhar, S, a další
Vydáno: (2008) -
Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
Autor: Folegatti, PM, a další
Vydáno: (2019) -
NEUTRALIZING ANTIBODY TITERS TO SIMIAN ADENOVIRAL VECTORS FOLLOWING ADCH63 ME-TRAP IMMUNIZATION IN HUMANS
Autor: Goodman, A, a další
Vydáno: (2009)